Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 3, 2010, Pages 481-489

  Zhao, Li ^a   Chen, Zhen ^a   Wang, Jun ^a   Yang, Li ^a   Zhao, Qing ^a   Wang, Jia ^a   Qi, Qi ^a   Mu, Rong ^a   You, Qi Dong ^a   Guo, Qing Long ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Hepatocellular carcinoma; Oroxylin A; Synergistic effect

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CYCLOOXYGENASE 2; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; LIPOCORTIN 5; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OROXYLIN A; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN P53; THYMIDYLATE SYNTHASE; ANTINEOPLASTIC AGENT; FLAVONOID; PTGS2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRUCTURE; CELL TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; STAINING; WESTERN BLOTTING; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DIHYDROURACIL DEHYDROGENASE (NADP); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FLAVONOIDS; FLUOROURACIL; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MOLECULAR STRUCTURE; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDYLATE SYNTHASE; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 75549090845     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1053-2     Document Type: Article

References (34)

1. CK Carrico RI Glazer 1979 Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver Cancer Res 39 3694 3701 1:CAS:528:DyaE1MXlvVKlur8%3D 476694
2. Y Chen L Yang TJ Lee 2000 Oroxylin A inhibition of lipopolysaccharide- induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation Biochem Pharmacol 59 1445 1457 10.1016/S0006-2952(00)00255-0 1:CAS:528:DC%2BD3cXit1Wnu7Y%3D 10751555 (Pubitemid 30177363)
3. YC Cheung SF Ko SH Ng SC Chan YF Cheng 2005 Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-lipiodol mixture in treating hepatocellular carcinoma World J Gastroenterol 11 2792 2795 15884125
4. TC Chou 2006 Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharmacol Rev 58 621 681 10.1124/pr.58.3.10 1:CAS:528:DC%2BD28XhtVOhtLfL 16968952 (Pubitemid 44403686)
5. TC Chou RJ Motzer Y Tong GJ Bosl 1994 Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design J Natl Cancer Inst 86 1517 1524 10.1093/jnci/86.20.1517 1:CAS:528: DyaK2cXmvFWru7w%3D 7932806
6. TC Chou P Talalay 1984 Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 27 55 10.1016/0065-2571(84)90007-4 1:CAS:528:DyaL2cXktlaksLk%3D 6382953
7. M Ebara S Okabe K Kita N Sugiura H Fukuda M Yoshikawa F Kondo H Saisho 2005 Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation J Hepatol 43 458 464 10.1016/j.jhep.2005.03.033 1:CAS:528:DC%2BD2MXntVCku7w%3D 16005538 (Pubitemid 41111427)
8. JL Fischel MC Etienne T Spector P Formento N Renee G Milano 1995 Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation Clin Cancer Res 1 991 996 1:CAS:528:DyaK2MXoslSmt78%3D 9816071
9. Y Hu Y Yang QD You W Liu HY Gu L Zhao K Zhang W Wang XT Wang QL Guo 2006 Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity Biochem Biophys Res Commun 351 521 527 10.1016/j.bbrc.2006.10.064 1:CAS:528:DC%2BD28XhtFOjtrnM 17069758 (Pubitemid 44666718)
10. WH Huang AR Lee CH Yang 2006 Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI Biosci Biotechnol Biochem 70 2371 2380 10.1271/bbb.50698 1:CAS:528:DC%2BD28XhtFynu7%2FO 17031041 (Pubitemid 44656401)
11. C Kawamoto K Ido N Isoda M Hozumi N Nagamine K Ono Y Sato Y Kobayashi G Nagae K Sugano 2005 Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation Cancer 103 985 993 10.1002/cncr.20880 15672389 (Pubitemid 40270075)
12. DH Kim SJ Jeon KH Son JW Jung S Lee BH Yoon JJ Lee YW Cho JH Cheong KH Ko JH Ryu 2007 The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice Neurobiol Learn Mem 87 536 546 10.1016/j.nlm.2006.11.005 1:CAS:528:DC%2BD2sXjs12gsbY%3D 17196405 (Pubitemid 46505108)
13. DH Kim S Kim SJ Jeon KH Son S Lee BH Yoon JH Cheong KH Ko JH Ryu 2008 The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice Neuropharmacology 55 639 647 10.1016/j.neuropharm. 2008.05.019 1:CAS:528:DC%2BD1cXhtFajtbbF 18620712
14. JY Kim S Lee DH Kim BR Kim R Park BM Lee 2002 Effects of flavonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes J Toxicol Environ Health A 65 373 381 10.1080/15287390252808046 1:CAS:528:DC%2BD38Xis1Ogtrw%3D 11936218 (Pubitemid 34264153)
15. ME Kitchens AM Forsthoefel KW Barbour HT Spencer FG Berger 1999 Mechanisms of acquired resistance to thymidylate synthase inhibitors: the role of enzyme stability Mol Pharmacol 56 1063 1070 1:CAS:528:DyaK1MXntV2ls74%3D 10531414
16. HB Li F Chen 2005 Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography J Chromatogr A 1074 107 110 10.1016/j.chroma. 2005.03.088 1:CAS:528:DC%2BD2MXjs1Klurs%3D 15941045 (Pubitemid 40615049)
17. JM Llovet 2005 Updated treatment approach to hepatocellular carcinoma J Gastroenterol 40 225 235 10.1007/s00535-005-1566-3 15830281 (Pubitemid 40613379)
18. SC Ma J Du PP But XL Deng YW Zhang VE Ooi HX Xu SH Lee SF Lee 2002 Antiviral Chinese medicinal herbs against respiratory syncytial virus J Ethnopharmacol 79 205 211 10.1016/S0378-8741(01)00389-0 1:CAS:528: DC%2BD38XktFamsQ%3D%3D 11801383 (Pubitemid 34136952)
19. AA Piper RM Fox 1982 Biochemical basis for the differential sensitivity of human T- and B-lymphocyte lines to 5-fluorouracil Cancer Res 42 3753 3760 1:CAS:528:DyaL38Xltlyhurw%3D 6179610
20. D Salonga KD Danenberg M Johnson R Metzger S Groshen DD Tsao-Wei HJ Lenz CG Leichman L Leichman RB Diasio PV Danenberg 2000 Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase Clin Cancer Res 6 1322 1327 1:CAS:528:DC%2BD3cXjtVOqt74%3D 10778957
21. E Sasaki K Tominaga H Kuwamura T Watanabe Y Fujiwara N Oshitani K Higuchi T Arakawa 2007 Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2, 4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism J Gastroenterol 42 816 822 10.1007/s00535-007-2101-5 1:CAS:528:DC%2BD2sXhtFyrur3F 17940834 (Pubitemid 47617459)
22. M Sonoda T Nishiyama Y Matsukawa M Moriyasu 2004 Cytotoxic activities of flavonoids from two Scutellaria plants in Chinese medicine J Ethnopharmacol 91 65 68 10.1016/j.jep.2003.11.014 1:CAS:528:DC%2BD2cXhsV2rtLs%3D 15036470 (Pubitemid 38270229)
23. CP Spears AH Shahinian RG Moran C Heidelberger TH Corbett 1982 In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas Cancer Res 42 450 456 1:CAS:528:DyaL38XhtlGntrs%3D 6173112
24. Y Sun XM Tang E Half MT Kuo FA Sinicrope 2002 Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells Cancer Res 62 6323 6328 1:CAS:528:DC%2BD38XosF2msbg%3D 12414664
25. R Tateishi S Shiina T Teratani S Obi S Sato Y Koike T Fujishima H Yoshida T Kawabe M Omata 2005 Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases Cancer 103 1201 1209 10.1002/cncr.20892 15690326 (Pubitemid 40328091)
26. AB van Kuilenburg J Haasjes DJ Richel L Zoetekouw H Van Lenthe RA De Abreu JG Maring P Vreken AH van Gennip 2000 Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene Clin Cancer Res 6 4705 4712 11156223
27. B Van Triest HM Pinedo G Giaccone GJ Peters 2000 Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors Ann Oncol 11 385 391 10.1023/A:1008351221345 10847455 (Pubitemid 30333539)
28. Y Wada K Yoshida T Suzuki H Mizuiri K Konishi K Ukon K Tanabe Y Sakata M Fukushima 2006 Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines Int J Cancer 119 783 791 10.1002/ijc.21879 1:CAS:528:DC%2BD28XntVeqtrY%3D 16557585 (Pubitemid 44055889)
29. X Wang J Zhang T Xu 2008 Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy Eur J Pharmacol 579 66 73 10.1016/j.ejphar.2007.10.012 1:CAS:528:DC%2BD1cXivVOntg%3D%3D 18028906
30. Y Yang Y Hu HY Gu N Lu W Liu Q Qi L Zhao XT Wang QD You QL Guo 2008 Oroxylin A induces G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells J Pharm Pharmacol 60 1459 1463 10.1211/jpp/60.11.0006 1:CAS:528:DC%2BD1cXhsVSmsr7M 18957166
31. Y Yang L Yang QD You FF Nie HY Gu L Zhao XT Wang QL Guo 2007 Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes Cancer Lett 256 259 266 10.1016/j.canlet.2007.06.014 1:CAS:528:DC%2BD2sXhtVOisLvE 17693016 (Pubitemid 47418351)
32. KS Yee KH Vousden 2005 Complicating the complexity of p53 Carcinogenesis 26 1317 1322 10.1093/carcin/bgi122 1:CAS:528:DC%2BD2MXmsV2itr0%3D 15888490 (Pubitemid 41430092)
33. EK Yim KH Lee JS Bae SE Namkoong SJ Um JS Park 2004 Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells DNA Cell Biol 23 769 776 10.1089/dna.2004.23.769 1:CAS:528: DC%2BD2cXhtVWgtLfJ 15585135
34. J Yu QL Guo QD You L Zhao HY Gu Y Yang HW Zhang Z Tan X Wang 2007 Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells Carcinogenesis 28 632 638 10.1093/carcin/bgl168 1:CAS:528:DC%2BD2sXjslOnsr0%3D 17012222 (Pubitemid 46523358)